HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumour activity of paclitaxel and interferon-alpha in a case of metastatic eccrine porocarcinoma.

AbstractBACKGROUND:
Eccrine porocarcinoma (EP) is a rare malignant tumour arising in the acrosyringium, with about 50% of the cases developing local recurrence or metastatic disease. No standard therapy protocols for metastatic disease exist. In the past, only short remissions were achieved by applying combinations of cytotoxic agents, which were associated with severe side-effects.
AIM OF THE STUDY:
In the case reported here, the aim was to find a protocol with fewer side-effects for a patient who was not willing to undergo extensive polychemotherapy.
SUBJECT:
A 67-year-old male patient with local recurrence and regional lymph node metastases after resection of EP was treated with a combination of interferon-alpha (IFN-alpha) 9 million units s.c. three times per week and paclitaxel 100 mg/m(2) weekly i.v., which shows a side-effect profile similar to taxotere and is used in the treatment of a variety of neoplasms such as advanced squamous cell carcinoma.
MAIN OUTCOME:
This less aggressive treatment was tolerated well and the patient responded with minor remission and long-term stable disease.
AuthorsJ Gutermuth, H Audring, C Voit, U Trefzer, N Haas
JournalJournal of the European Academy of Dermatology and Venereology : JEADV (J Eur Acad Dermatol Venereol) Vol. 18 Issue 4 Pg. 477-9 (Jul 2004) ISSN: 0926-9959 [Print] England
PMID15196167 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Paclitaxel
Topics
  • Acrospiroma (drug therapy, pathology)
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Humans
  • Interferon alpha-2
  • Interferon-alpha (administration & dosage)
  • Lymphatic Metastasis
  • Male
  • Paclitaxel (administration & dosage)
  • Recombinant Proteins
  • Sweat Gland Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: